Life Pack Organics has created the Emergen-C for the CBD industry and is offering a once in a lifetime opportunity to disrupt Big Pharma by bringing these products to the world.
Formed in 2018, Los Angeles based Life Pack Organics, Inc. (www.lifepackorganics.com) is a company that specializes in the production of scientifically formulated nutrition and wellness products for today’s health conscientious consumers. Our proprietary blends are organic, 100% vegan, cruelty free and developed by Master Chemists in our labs which have been in existence for over 50 years.
Our first product release is a beverage additive with a proprietary blend of ingredients including hemp based crystallized cannabidiol (CBD). The product contains vitamins and nutrients that aid and combat pain, reduce anxiety, improve sleep and overcome general malaise. LPO also includes 5g of dietary fiber that has been scientifically proven to improve cardiovascular health and digestion. LPO comes in crystallized form, is water soluble, and can be added to your favorite beverage and is the equivalent to Emergen-C, but with additional health benefits of CBD. LPO contains No THC, rather it contains a beneficial dosage of CBD making it safe for children and anyone seeking a holistic approach to wellness or those who utilize CBD as an alternative to prescription drugs.
LPO will be available at drug stores, retailers, grocery stores and online. The product will be sold in individual servings, by the box and in a 30-day supply. For the first time in history, consumers will be able to experience the tremendous benefits of CBD by logging onto www.lifepackorganics.com. This is a perfect solution for busy individuals on the go. Life Pack Organics come in easy to transport individual packs for travel convenience.
Life Pack Organics is poised the be the first company to make this type of product available to consumers. By capturing .01% of the estimated 2020 revenues of $2.15 billion, LPO would generate approximately $21.5 million in revenues. We are building Brand equity and generating revenue to take Life Pack Organics public in 2020.
We launched our idea to create a company that could change the way people think about their daily life.November, 2018
Life Pack Organics Inc,. established relationships with labs to engage in R&D for our proprietary blend.December, 2018
Partnered with West Coast Labs to produce our fully soluble, 100% Natural & Organic, Vegan CBD blend to add into any beverage.May, 2019
Launched our all natural Luxury Spa Line along with our Sports Recovery Line making LPO first to market with CBD Plant Based ProteinsOctober, 2019
Launched full line of products and sold out to a distributor further providing "proof of concept".January, 2020
Life Pack Organics signed Sinbad, the Comedian, as our Key Brand Ambassador representing us across all social media platforms.February, 2020
Partnered & signed distribution agreement with 7Eleven Franchisee owner to provide LPO products in 9 out of 7,600 US based convenient storesApril, 2020
Launch Crowdfunder campaign to bring Life Pack Organics to every person on the planet. God Bless and lets have some fun.April, 2020
Life Pack Organics (“LPO”) Enters into a Letter of Intent to Joint Venture with ALAMidas Capital Partners (“ACP”)August, 2020
For Immediate Release - LEGENDARY ROCK DRUMMER SIMON WRIGHT JOINS THE LIFE PACK ORGANICS ALL STAR TEAM Los Angeles, CA, September 3rd, 2020September, 2020
In states where MMJ is legal, any CBD product (whether it comes from hemp or marijuana) is of course perfectly legal. Outside of these legalized states (including shipping from legal to non-legal states), things tend to be a little less clear. According to ProjectCBD.org, “Federal law prohibits U.S. farmers from cultivating hemp as a commercial crop, but the sale of imported, low-THC, industrial hemp products is permitted in the United States.” Technically, this means that as long as the CBD product (oil, vape, topical, etc) is produced from the seeds and stalk of the industrial hemp plant (with less than 0.3% THC), it is permissible to buy, sell, and ship across state lines. (However, in articles like 2014’s Farm Bill, the exact rule seems to be a little less clear). All in all, the fact remains that millions of people buy and use CBD products every day of their lives, and this option is only getting more popular and widespread with each passing day.
Marijuana and hemp are two different varieties of cannabis that come from the same species of plant (Cannabis sativa L). In general, CBD is found abundantly in both. However, it’s important to note that CBD is typically found in the seeds and stem of marijuana - not in the flowering buds (which is the part that you smoke). The hemp plant is an entirely different strain of cannabis that contains high quantities of CBD throughout (stem, buds, etc), and practically zero traces of THC. If a hemp plant contains more than 0.3% THC, it is then technically a “marijuana” plant. Most all CBD-based products come from the industrial hemp plant.
CBD functions by binding to cannabinoid receptors in the body’s endocannabinoid system. These receptors have been found in virtually every cell and tissue type in the human body (hence the seemingly endless array of CBD uses).
THC affects the brain by binding to naturally occurring CB-1 receptors in the central nervous system. CBD is a differently shaped molecule that binds to CB-2 receptors in cell and body tissues outside the central nervous system.
No, CBD will not get you high. It's non-intoxicating. Like we just said THC is the molecule that binds to receptors in our brain and is the one responsible for the psychoactive effects of marijuana. In fact, CBD is antagonistic to the marijuana high; some research expresses its potential to prevent THC molecules from binding to the brain’s receptors (hence the reason it’s often used to subdue the ‘paranoia’ effects of super-potent THC strains).
The only significant danger/side effect of the drug is in vaping CBD oils that were produced using a thinning agent, such as propylene glycol. When burned/vaped, propylene glycol produces formaldehyde, which is a known carcinogen. CBD oils produced by CO2 extraction are much safer and purer than oils that were produced with liquid alcohol/thinning agents. Other than that, most research has concluded that CBD is perfectly safe with no known side effects, though some users have reported drowsiness, lightheadedness, low blood pressure, and dry mouth.
CBD topicals have proven effective for several circumstances. Many individuals swear by them.
To ensure the legality of buying CBD products online, you need to make sure the company you’re buying from is reputable and that the product was made from industrial hemp with less than 0.3% THC content. While transporting marijuana across state lines (from legal to non-legal states) is against the law, transporting hemp and hemp-based products is safe. Remember, millions of people all over the US (and the globe) are using CBD products every day.
Investing in common stock involves a high degree of risk. Potential investors should carefully consider all risk factors and information contained in this prospectus before purchasing Company stock. There are associated risks and uncertainties beyond those described herein that affect our business. There may be additional risks and uncertainties of which we are unaware or currently deem immaterial that may impact our business. Should we become subject to any of these circumstances, our business, financial condition or results of operations could be materially and adversely affected in which the value of our stock could decline. Investors may lose a portion or all of the investment.
Company success depends on the viability of our business model. Our business model is based on opportunities in both the Cannabidiol (CBD) and Health and Wellness/Fitness markets with a variety of speculation and assumptions relating to industry trends, state and local legislation around compliance of the CBD industry.
Life Pack Organics Inc. business model is unproven. Our profit and income potential are contingent upon variables which may extend beyond our control. As a direct result, our business model/financial success could differ materially from those projections included.
To achieve success, we must:
Our business will suffer if we are unable to accomplish these and other important business objectives. We are uncertain as to when, or whether, we will fully implement our contemplated business plan and strategy or become profitable.
Our financial position, liquidity and results of operations depend on our management team’s ability to execute our business strategy. Knowledge of an industry’s prospects and risks are an important part of the valuation process. No business can be valued in a vacuum as the performance of a business is dependent on industry trends and other external factors. This is especially relevant in the CBD and beverage industry, as a myriad of industry-specific risks and uncertainties need to be incorporated into the valuation process.
AGRICULTURE IMPROVEMENT ACT OF 2018 (FARM BILL)
*SEC. 10113. HEMP PRODUCTION.
The Agricultural Marketing Act of 1946 (7 U.S.C. 1621 et seq.) is amended by adding at the end the following:
“Subtitle G—Hemp Production
“SEC. 297A. DEFINITIONS.
“In this subtitle:
“(1) HEMP. —The term ‘hemp’ means the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis.
SEC. 10114. INTERSTATE COMMERCE.
**With the issuance of this final order, the Acting Administrator of the Drug Enforcement Administration places certain drug products that have been approved by the Food and Drug Administration (FDA) and which contain cannabidiol (CBD) in schedule V of the Controlled Substances Act (CSA). Specifically, this order places FDA-approved drugs that contain CBD derived from cannabis and no more than 0.1 percent tetrahydrocannabinols in schedule V. This action is required to satisfy the responsibility of the Acting Administrator under the CSA to place a drug in the schedule he deems most appropriate to carry out United States obligations under the Single Convention on Narcotic Drugs, 1961. Also consistent therewith, DEA is adding such drugs to the list of substances that may only be imported or exported pursuant to a permit.
DATES: Effective September 28, 2018.
Banks and credit card issuers are very cautious of working this industry due to concerns over enforcement at the federal level and fears that they will fall victim to charges of money laundering or other alleged felonies. The compliance requirements for these institutions will eventually lead to banks closing all accounts associated with the marijuana industry. Consequently, most dispensaries operate in an “all cash” environment, which makes each operation more susceptible to crimes by employees or outsiders. Further, the banking industry’s reluctance to accept this industry makes it harder for potential marijuana businesses to purchase real estate, due to a shortage of lenders. Similarly, it is often difficult to persuade a potential landlord to lease space, as the landlord may worry about seizure of his or her property and the closure of their bank accounts.
The Cannabidiol industry is laden with both opportunities and risk. For small business owners that can tolerate risk, significant tax bills, heavy regulatory scrutiny, and a lingering moral stigma, an efficient operator with good business practice can generate significant profits. While some local financial institutions are quietly accepting industrial hemp business clients, most major banks and credit unions are still reluctant to service the industry out of fear of being penalized for money laundering.
Subject to substantial federal and state regulations
The Company’s research and development activities and the manufacturing and marketing of the Company’s products may be subject to the laws, regulations, and guidelines and, in some cases, regulatory approvals of governmental authorities in the United States.
The Company cannot be sure that the governments will not question its advertising or other activities in the future. In addition, the Company cannot predict whether new legislation or regulations governing the Company’s activities will be enacted by legislative bodies or promulgated by agencies further regulating or restricting the Company’s activities, or what the effect of any such legislation or regulations may be upon the Company’s business.
While the Company has retained counsel to advise and assist it on issues of compliance, it is possible that regulatory changes could occur which could detrimentally affect the Company’s ability to market and sell its products and/or services. In addition, regulatory changes could affect the Company’s advertising in a manner that could negatively affect earnings.
We intend to use the proceeds from this offering for general corporate purposes, including working capital and acquisition of raw materials to further enhance product lines. In any case, we will have broad discretion over how we use these proceeds. You will not have the opportunity to evaluate the economic, financial or other information on which we base our decisions regarding how to use the proceeds from this offering, and we may spend these proceeds in ways with which you disagree. A limited number of stockholders collectively own a significant portion of our common shares and may act, or prevent corporate actions, to the detriment of other stockholders.
You should carefully consider the risk factors described below together with the information contained in the supporting documents before making an investment decision to invest in our Securities. While we believe these risks and uncertainties are the most important for you to consider an investment in the shares is a speculative investment and involves significant risks and should be made only by persons or entities that can afford the loss of their entire investment.
The following considerations do not constitute a complete discussion of the risks relating to “COMPANY”. An accurate appraisal of the risks of an investment in the shares can only be gained through an investor’s own due diligence. We may need Subsequent Financing; however, there is no Assurance that we will obtain it. If in fact we do not realize the Financing, as there is no such assurance that this can be accomplished, we will continue to operate the “COMPANY” using our own funds and talent, like we have done so far. Although we anticipate that upon realization and completion of the full amount of this Offering, we will be able to internally generate sufficient revenue to continue the expansion plans of the “COMPANY”, there cannot be any assurance that this can be accomplished. Consequently, we may determine a need to obtain additional financing which could cause dilution to subscribing shareholders to this offering but on the other hand, would most probably increase profits.